tm
Seeing Is Believing
tm
Seeing Is Believing
DRMA is currently covered by 1 analysts with an average price target of $70.74. This is a potential upside of $69.59 (6051.3%) from yesterday's end of day stock price of $1.15.
Dermata Therapeutics's activity chart (see below) currently has 2 price targets and 6 ratings on display. The stock rating distribution of DRMA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 133 days.
Highest price target for DRMA is $6, Lowest price target is $6, average price target is $70.74.
Most recent stock forecast was given by ANTHONY VENDETTI from MAXIM GROUP on 21-Aug-2024. First documented stock forecast 14-Sep-2021.
Currently out of the existing stock ratings of DRMA, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$6
$4.88 (435.71%)
$16
3 months ago
(21-Aug-2024)
1/4 (25%)
$4.06 (209.28%)
266
Buy
$224
2 years 7 months 7 days ago
(14-Apr-2022)
0/1 (0%)
$135.12 (152.03%)
What is DRMA (Dermata Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on DRMA (Dermata Therapeutics) with a proven track record?
Which analyst has the current lower performing score on DRMA (Dermata Therapeutics) with a proven track record?
Which analyst has the most public recommendations on DRMA (Dermata Therapeutics)?
Which analyst is the currently most bullish on DRMA (Dermata Therapeutics)?
Which analyst is the currently most reserved on DRMA (Dermata Therapeutics)?
